Vfend — Medica
Fungal infection (systemic) in a patient with human immunodeficiency virus (HIV) – prophylaxis or treatment
Initial criteria
- Approve for the indication(s) listed
Reauthorization criteria
- None specified beyond approval durations; reauthorization may be granted per listed durations
Approval duration
3 to 12 months depending on indication